Zurich Cantonal Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

Zurich Cantonal Bank’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,787	Closed	-$22.7K	–	2764
2023 Q3	$22.7K	Hold	20,787	–	–	﹤0.01%	2698
2023 Q2	$47.6K	Hold	20,787	–	–	﹤0.01%	2630
2023 Q1	$50.5K	Sell	20,787 -15,693	-43%	-$36K	﹤0.01%	2593
2022 Q4	$69.7K	Buy	36,480 +23,792	+188%	+$50.6K	﹤0.01%	2481
2022 Q3	$30K	Hold	12,688	–	–	﹤0.01%	2730
2022 Q2	$24K	Hold	12,688	–	–	﹤0.01%	2774
2022 Q1	$27K	Hold	12,688	–	–	﹤0.01%	2633
2021 Q4	$50K	Buy	+12,688	New	+$61.6K	﹤0.01%	2737
2020 Q2	–	Sell	-4,213	Closed	-$8K	–	2568
2020 Q1	$8K	Hold	4,213	–	–	﹤0.01%	2518
2019 Q4	$17K	Hold	4,213	–	–	﹤0.01%	2527
2019 Q3	$13K	Hold	4,213	–	–	﹤0.01%	2523
2019 Q2	$26K	Hold	4,213	–	–	﹤0.01%	2377
2019 Q1	$23K	Hold	4,213	–	–	﹤0.01%	2376
2018 Q4	$28K	Hold	4,213	–	–	﹤0.01%	2332
2018 Q3	$45K	Hold	4,213	–	–	﹤0.01%	2209
2018 Q2	$51K	Hold	4,213	–	–	﹤0.01%	2113
2018 Q1	$36K	Buy	4,213 +2,876	+215%	+$26.6K	﹤0.01%	2238
2017 Q4	$13K	Hold	1,337	–	–	﹤0.01%	2471
2017 Q3	$16K	Hold	1,337	–	–	﹤0.01%	2327
2017 Q2	$22K	Hold	1,337	–	–	﹤0.01%	2216
2017 Q1	$19K	Hold	1,337	–	–	﹤0.01%	2324
2016 Q4	$18K	Hold	1,337	–	–	﹤0.01%	2301
2016 Q3	$24K	Buy	1,337 +374	+39%	+$6.02K	﹤0.01%	2167
2016 Q2	$14K	Hold	963	–	–	﹤0.01%	2254
2016 Q1	$12K	Hold	963	–	–	﹤0.01%	2292
2015 Q4	$13K	Hold	963	–	–	﹤0.01%	2281
2015 Q3	$10K	Buy	+963	New	+$10.5K	﹤0.01%	2004

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Zurich Cantonal Bank's LXRX Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2023, closing a stake of 20,787 shares — an estimated $22.7K sold.

Zurich Cantonal Bank first reported a position in LXRX in Q3 2015 and held it in 27 quarters. The position peaked at $69.7K in Q4 2022. 106 funds tracked by Wall St. Rank hold LXRX as of Q4 2023.

Zurich Cantonal Bank reported no remaining Lexicon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 20,787 Lexicon Pharmaceuticals shares in Q4 2023, an estimated $22.7K.
Zurich Cantonal Bank first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 27 quarters.
Zurich Cantonal Bank's Lexicon Pharmaceuticals position peaked at $69.7K in Q4 2022.
106 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.